| |
| |
|
| Insider
Information: |
Patel Sushil |
| Relationship: |
|
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
247,908 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,244,986 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
247,908 |
|
|
| Total
Value |
$2,244,986 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Replimune Group Inc |
REPL |
Chief Executive Office... |
2024-04-01 |
232,208 |
2021-05-03 |
0 |
Premium* |
|
|
Revolution Medicines, Inc. |
RVMD |
|
2024-04-10 |
15,700 |
2022-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RVMD |
Revolution Medicines, Inc... |
|
• • – |
2024-04-10 |
4 |
AS |
$37.00 |
$79,735 |
D/D |
(2,155) |
15,700 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
|
• • – |
2024-04-10 |
4 |
OE |
$16.80 |
$36,204 |
D/D |
2,155 |
17,855 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Executive Officer |
• • – |
2024-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
83,335 |
232,208 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Strategy Officer |
• – – |
2023-06-13 |
4 |
AS |
$23.44 |
$137,008 |
D/D |
(5,698) |
148,873 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
|
• • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,200 |
15,700 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Strategy Officer |
• – – |
2023-05-16 |
4 |
S |
$18.05 |
$281,129 |
D/D |
(15,575) |
154,571 |
0 |
% |
|
| RVMD |
Revolution Medicines, Inc... |
Director |
– • – |
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
10,500 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Commercial Officer |
• – – |
2022-05-16 |
4 |
S |
$14.59 |
$155,923 |
D/D |
(10,687) |
130,146 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Chief Commercial Officer |
• – – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
52,500 |
140,833 |
0 |
- |
|
| REPL |
Replimune Group Inc |
Chief Commercial Officer |
• – – |
2021-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
88,333 |
88,333 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
